Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Medical and surgical treatment options for polycystic liver disease.

Drenth JP, Chrispijn M, Nagorney DM, Kamath PS, Torres VE.

Hepatology. 2010 Dec;52(6):2223-30. doi: 10.1002/hep.24036. Review. No abstract available.

PMID:
21105111
2.

Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice.

Spirli C, Okolicsanyi S, Fiorotto R, Fabris L, Cadamuro M, Lecchi S, Tian X, Somlo S, Strazzabosco M.

Hepatology. 2010 May;51(5):1778-88. doi: 10.1002/hep.23511.

3.

Centrioles, centrosomes, and cilia in health and disease.

Nigg EA, Raff JW.

Cell. 2009 Nov 13;139(4):663-78. doi: 10.1016/j.cell.2009.10.036. Review.

4.

The transient receptor potential channels TRPP2 and TRPC1 form a heterotetramer with a 2:2 stoichiometry and an alternating subunit arrangement.

Kobori T, Smith GD, Sandford R, Edwardson JM.

J Biol Chem. 2009 Dec 18;284(51):35507-13. doi: 10.1074/jbc.M109.060228.

5.

ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice.

Spirli C, Okolicsanyi S, Fiorotto R, Fabris L, Cadamuro M, Lecchi S, Tian X, Somlo S, Strazzabosco M.

Gastroenterology. 2010 Jan;138(1):360-371.e7. doi: 10.1053/j.gastro.2009.09.005.

6.

Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial.

van Keimpema L, Nevens F, Vanslembrouck R, van Oijen MG, Hoffmann AL, Dekker HM, de Man RA, Drenth JP.

Gastroenterology. 2009 Nov;137(5):1661-8.e1-2. doi: 10.1053/j.gastro.2009.07.052.

PMID:
19646443
7.

Autosomal dominant polycystic kidney disease: the last 3 years.

Torres VE, Harris PC.

Kidney Int. 2009 Jul;76(2):149-68. doi: 10.1038/ki.2009.128. Review.

8.

Differentially expressed adenylyl cyclase isoforms mediate secretory functions in cholangiocyte subpopulation.

Strazzabosco M, Fiorotto R, Melero S, Glaser S, Francis H, Spirli C, Alpini G.

Hepatology. 2009 Jul;50(1):244-52. doi: 10.1002/hep.22926.

9.

Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1.

Distefano G, Boca M, Rowe I, Wodarczyk C, Ma L, Piontek KB, Germino GG, Pandolfi PP, Boletta A.

Mol Cell Biol. 2009 May;29(9):2359-71. doi: 10.1128/MCB.01259-08.

10.

Polycystic kidney disease.

Harris PC, Torres VE.

Annu Rev Med. 2009;60:321-37. doi: 10.1146/annurev.med.60.101707.125712. Review.

11.

Syntaxin 5 regulates the endoplasmic reticulum channel-release properties of polycystin-2.

Geng L, Boehmerle W, Maeda Y, Okuhara DY, Tian X, Yu Z, Choe CU, Anyatonwu GI, Ehrlich BE, Somlo S.

Proc Natl Acad Sci U S A. 2008 Oct 14;105(41):15920-5. doi: 10.1073/pnas.0805062105.

12.

Polycystin-1 C-terminal tail associates with beta-catenin and inhibits canonical Wnt signaling.

Lal M, Song X, Pluznick JL, Di Giovanni V, Merrick DM, Rosenblum ND, Chauvet V, Gottardi CJ, Pei Y, Caplan MJ.

Hum Mol Genet. 2008 Oct 15;17(20):3105-17. doi: 10.1093/hmg/ddn208.

13.

Functional anatomy of normal bile ducts.

Strazzabosco M, Fabris L.

Anat Rec (Hoboken). 2008 Jun;291(6):653-60. doi: 10.1002/ar.20664. Review.

14.

Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia.

Patel V, Li L, Cobo-Stark P, Shao X, Somlo S, Lin F, Igarashi P.

Hum Mol Genet. 2008 Jun 1;17(11):1578-90. doi: 10.1093/hmg/ddn045.

15.

Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development.

Fabris L, Cadamuro M, Libbrecht L, Raynaud P, Spirlì C, Fiorotto R, Okolicsanyi L, Lemaigre F, Strazzabosco M, Roskams T.

Hepatology. 2008 Feb;47(2):719-28.

PMID:
18157837
16.

Cholangiocyte cilia express TRPV4 and detect changes in luminal tonicity inducing bicarbonate secretion.

Gradilone SA, Masyuk AI, Splinter PL, Banales JM, Huang BQ, Tietz PS, Masyuk TV, Larusso NF.

Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19138-43.

17.

TRPP2: Ca2+-permeable cation channel and more.

Giamarchi A, Padilla F, Crest M, Honore E, Delmas P.

Cell Mol Biol (Noisy-le-grand). 2006 Dec 30;52(8):105-14. Review.

PMID:
17535744
18.

Polyductin undergoes notch-like processing and regulated release from primary cilia.

Kaimori JY, Nagasawa Y, Menezes LF, Garcia-Gonzalez MA, Deng J, Imai E, Onuchic LF, Guay-Woodford LM, Germino GG.

Hum Mol Genet. 2007 Apr 15;16(8):942-56.

19.

Regulation of ryanodine receptor-dependent calcium signaling by polycystin-2.

Anyatonwu GI, Estrada M, Tian X, Somlo S, Ehrlich BE.

Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6454-9.

20.

Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate.

Masyuk TV, Masyuk AI, Torres VE, Harris PC, Larusso NF.

Gastroenterology. 2007 Mar;132(3):1104-16.

PMID:
17383431
Items per page

Supplemental Content

Support Center